J Korean Cancer Assoc.
2000 Feb;32(1):100-109.
Detection of Human Papillomavirus DNA and p53 , p21 Gene
Expression in CIN3 and Uterine Cervical Cancer
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Namkwang General Hospital,
College of Medicine, Seonam University, Kwangju.
- 2Department of Obstertrics and Gynecology, College of Medicine,
Chonnam University, Kwangju, Korea.
Abstract
-
PURPOSE: Though the etiology of this cancer has not been elucidated,
it has been suggested that certain types of human papillomavirus (HPV)
and alteration of the p53 gene are closely associated with uterine cervical
cancer. The aim of the study was to investigate the role of high risk HPV,
p53 and p21 gene in cervical intraepithelial neoplasia III (CIN3) and
invasive squamous cell carcinoma.
MATERIALS AND METHODS
The presence of high-risk HPV DNA
(16, 18, 31, 33, 35, 45, 51, 52, 56) were detected from cervical swab
in 240 patients by hybrid capture method. Expression of p53 genes were
studied in paraffin-embedded specimens by immunohisto- chemical staining
and p53, p21 gene alteration by RT-PCR SSCP using fresh cervical tissues.
RESULTS
High risk HPV DNA were detected in 34%, 74.3% and 75.7% in control,
CIN3 and invasive squamaus cell carcinoma respectively. In patients with high
risk HPV DNA, type 16 were detected of 5.9%, 30.8%, 47.2% respectively.
Relative concentration of HPV DNA to control was 16.3+-27.4 in CIN3 and
30.4+-40.8 in invasive squamous cell cancer. Of patients with high risk
HPV DNA, p53 expression was found in 42.9% of CIN3 immunohistochemically,
while patients with invasive squamous cell carcinoma was de- tected in 50%.
In patients without high risk HPV DNA, p53 expression was detected in 17.1%
in CIN3, 15.7% in invasive squamous cell carcinoma. But the mutation of p53
and p21 gene by RT-PCR SSCP were not observed in CIN3 and invasive squamous
cell carcinoma.
CONCLUSION
These observations suggest that carcinogenesis of invasive
squamous cell carcinoma from CIN3 may be concerned with high risk HPV
concentration and may be occurred via another pathway without HPV and
p53 or p21 mutation.